Patents by Inventor Laura S. Privalle

Laura S. Privalle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
    Patent number: 6939711
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5? regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3? termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5? regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3? termination region.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: September 6, 2005
    Assignee: Syngenta Investment Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
    Publication number: 20010022004
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3′ termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3′ termination region.
    Type: Application
    Filed: March 21, 2001
    Publication date: September 13, 2001
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Method of controlling the fertility of a plant
    Patent number: 6147282
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: November 14, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
    Patent number: 5880333
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: March 9, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle